Recruiting
Phase 3

Alendronate

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT00346190

Conditions

Osteoporosis

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Alendronate

Study Details

Brief summary:

To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture

Conditions

Osteoporosis

Study ID

NCT00346190

Start date

Jan, 2003

Status verified date

Jan, 2006

Completion date

Apr, 2007

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Male and Female aged > 55 Low trauma hip fracture up to 90 days Be willing to submit to periodic bone mineral density radiographic studies of the spine \& 24 hr urine collection Written informed consent

-

Exclusion Criteria:

  • Disorders known to affect bone metabolism Not taking bisphosphonates within last 6 months Drugs known to interfere with calcium metabolism within the lats 6 months prior to hip fracture serum calcium> 2.65 mmol/L Treatment with any investigational drug within the last 30 days

Study Design

Enrollment

10 participants

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Interventions

Alendronate

Central Contacts and Locations

Central contacts

Richard Kremer, MD PhD

514-934-1934

Giselle Charrette, RN CONc

514-934-1934giselle.charrette@muhc.mcgill.ca

Locations

Mcgill University Health center

Recruiting

Montreal, Quebec, Canada, H3A 1A1

Contacts

Richard Kremer, MD PhD

514-934-1934

Principal Investigator:

Richard Kremer, MD PhD FRCP(c)

More Information

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Last update posted

Apr 12, 2007

Last verified

Jan, 2006

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-03. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2007-04-12.